Ophthalmology Glaucoma

Scope & Guideline

Shaping the Future of Glaucoma Care

Introduction

Immerse yourself in the scholarly insights of Ophthalmology Glaucoma with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2589-4234
PublisherELSEVIER
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2018 to 2024
AbbreviationOPHTHALMOL GLAUCOMA / Ophthalmol. Glaucoma
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Ophthalmology Glaucoma' serves as a prominent platform for advancing knowledge in the field of glaucoma, focusing on both clinical and experimental research to improve patient outcomes.
  1. Clinical Research and Treatment Outcomes:
    The journal emphasizes studies that evaluate clinical practices, treatment efficacy, and surgical outcomes in glaucoma management, including comparisons of various surgical techniques and medications.
  2. Innovative Diagnostic Techniques:
    There is a strong focus on the development and validation of new diagnostic tools and imaging technologies, such as OCT and AI applications, to enhance the understanding of glaucoma progression and management.
  3. Epidemiological Studies and Risk Factors:
    Research addressing the epidemiology of glaucoma, including risk factors and demographic studies, helps to understand the disease's impact across different populations.
  4. Patient-Centered Research:
    The journal publishes studies related to patient-reported outcomes, quality of life, and adherence to treatment, highlighting the importance of patient perspectives in glaucoma care.
  5. Technological Advances in Glaucoma Management:
    Papers exploring the role of technology in glaucoma monitoring and treatment, including telemedicine and digital health solutions, are a key component of the journal's scope.
The journal has identified several emerging themes that reflect current trends and advancements in glaucoma research, showcasing the evolving landscape of the field.
  1. Telemedicine and Remote Monitoring:
    As seen from recent publications, there is a growing trend towards telehealth solutions for glaucoma management, driven by the need for accessible care and monitoring, particularly highlighted during the COVID-19 pandemic.
  2. Artificial Intelligence and Machine Learning:
    The integration of AI in glaucoma diagnosis and management is on the rise, with studies exploring its potential for improving diagnostic accuracy and predicting disease progression.
  3. Minimally Invasive Glaucoma Surgery (MIGS):
    MIGS techniques are increasingly featured, reflecting a trend towards less invasive procedures that aim to reduce complications and recovery times for patients.
  4. Patient Engagement and Education:
    Research focusing on enhancing patient knowledge and adherence through educational interventions and digital resources is emerging as a significant theme, emphasizing the role of informed patients in effective glaucoma management.
  5. Socioeconomic and Racial Disparities in Glaucoma Care:
    An increasing number of studies address the impact of social determinants of health on glaucoma diagnosis and treatment, highlighting the need for equitable healthcare solutions.

Declining or Waning

While the journal covers a broad range of topics, certain areas of focus have seen a decline in prominence over recent years, reflecting shifts in research interests and advancements in technology.
  1. Traditional Surgical Techniques:
    There appears to be a decreasing emphasis on traditional surgical methods as newer, less invasive techniques gain popularity, indicating a shift towards minimally invasive glaucoma surgeries.
  2. Pharmacological Treatments:
    Research centered around older pharmacological treatments for glaucoma is becoming less frequent, as newer agents and combination therapies are explored, suggesting a transition in focus towards innovative therapeutic options.
  3. General Reviews and Meta-Analyses:
    The frequency of general review articles and meta-analyses has diminished, possibly due to a growing preference for original research that offers new insights and data.
  4. Basic Science and Mechanistic Studies:
    Although still relevant, there is a noticeable decline in publications focusing solely on the basic science of glaucoma pathophysiology, as applied research and clinical applications take precedence.

Similar Journals

Urogynecology

Exploring breakthroughs in women's pelvic floor disorders.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 12 issues/year

Urogynecology, published by Lippincott Williams & Wilkins, is a distinguished journal that serves as an essential platform for researchers, clinicians, and students in the fields of obstetrics, gynecology, surgery, and urology. With an impact factor that places it in the Q2 category in various specialties, the journal emphasizes high-quality, peer-reviewed research that contributes to advancements in women's health and pelvic floor disorders. As an Open Access journal, it is committed to enhancing the accessibility of its content, allowing for broader dissemination of knowledge and fostering collaborative efforts in the medical community. Located in India and addressing a global audience, Urogynecology has quickly established its reputation since its inception in 2022, continuing through its converged years until 2024. It is ranked favorably in Scopus across several medical categories, providing a vital resource for cutting-edge research and clinical practice insights. This journal aims to bridge gaps in knowledge and practice, making it an invaluable asset for anyone dedicated to improving outcomes in urogynecology.

Scandinavian Journal of Urology

Shaping the future of urology and nephrology.
Publisher: Medical Journal Sweden ABISSN: 2168-1805Frequency: 1 issue/year

Welcome to the Scandinavian Journal of Urology, a dynamic platform dedicated to advancing the fields of urology and nephrology. Published by Medical Journal Sweden AB and located in the United Kingdom, this esteemed journal features open access options that enhance the accessibility of cutting-edge research to a global audience. With an impressive impact factor and a respectable position in Scopus rankings—#55/120 in Urology and #45/81 in Nephrology—the journal occupies a vital niche for researchers, clinicians, and students eager to share and engage with pioneering studies from 2013 to 2024. As part of the Q2 quartile in both urology and nephrology categories, the Scandinavian Journal of Urology plays a crucial role in informing and shaping contemporary clinical practices and research directions. Join us in exploring the latest developments and evidence-based findings in these essential areas of medical science.

JOURNAL OF GLAUCOMA

Advancing glaucoma research for better patient outcomes.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1057-0829Frequency: 12 issues/year

JOURNAL OF GLAUCOMA is a premier academic journal dedicated to the field of ophthalmology, specializing in glaucoma research and management. Published by Lippincott Williams & Wilkins, this journal plays a pivotal role in disseminating cutting-edge research findings, clinical advancements, and evidence-based practices that address the challenges associated with glaucoma. With an impressive impact factor and categorized in the Q1 quartile in Ophthalmology as of 2023, the journal ranks #38 out of 137 in the Medicine – Ophthalmology category, placing it in the 72nd percentile amongst its peers. Since its inception in 1992, the journal has provided a vital forum for both emerging and established researchers, combining innovative studies with practical insights to enhance patient care. Although the journal is not open access, it remains committed to reaching a wide audience of professionals and students, ensuring they stay abreast of the latest developments in the field. For researchers and practitioners alike, JOURNAL OF GLAUCOMA is an essential resource for advancing knowledge and practices in glaucoma management.

Spektrum der Augenheilkunde

Illuminating the Path to Eye Health
Publisher: SPRINGER WIENISSN: 0930-4282Frequency: 6 issues/year

Welcome to Spektrum der Augenheilkunde, a distinguished journal published by SPRINGER WIEN, dedicated to the field of ophthalmology since its inception in 1987. With an ISSN of 0930-4282 and an E-ISSN of 1613-7523, this journal is recognized for its commitment to publishing original research, reviews, and clinical studies that address current and emerging topics in eye health and treatment. Although classified in the Q4 category for ophthalmology as per the latest 2023 rankings, it serves as a valuable platform for researchers, professionals, and students looking to contribute to and expand their knowledge in this vital area of medicine. Based in Austria and accessible through various academic databases, the journal aims to foster communication among professionals and advance the understanding of ocular diseases, innovative therapies, and clinical best practices.

BMJ Open Ophthalmology

Advancing Visionary Research in Ophthalmology
Publisher: BMJ PUBLISHING GROUPISSN: 2397-3269Frequency: 1 issue/year

BMJ Open Ophthalmology is an esteemed, open-access journal dedicated to the field of ophthalmology, published by the renowned BMJ Publishing Group. Established in 2016, this journal has quickly made its mark within the ophthalmology community, achieving a respectable Q2 ranking in the 2023 category quartiles. It is indexed in Scopus, boasting a commendable ranking of **#52** out of **137** in the medicine discipline of ophthalmology, placing it in the **62nd percentile**. This global platform is committed to disseminating high-quality research, clinical studies, and innovative practices that propel the understanding and treatment of eye diseases. With its open access model, BMJ Open Ophthalmology ensures that vital research is readily available to health professionals, researchers, and students, fostering collaboration and advancing knowledge within the field. The journal is based in London, United Kingdom, and continues to welcome submissions that explore the latest advancements in ophthalmic science, contributing to enhanced patient care and outcomes.

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA

Elevating the standards of ophthalmology through shared knowledge.
Publisher: CONSEL BRASIL OFTALMOLOGIAISSN: 0004-2749Frequency: 6 issues/year

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA is a prominent peer-reviewed journal dedicated to the field of ophthalmology, published by CONSEL BRASIL OFTALMOLOGIA since its inception in 1945. With its commitment to disseminating high-quality research, the journal has transitioned to an Open Access model since 2001, ensuring that vital findings in ophthalmology are freely available to researchers, clinicians, and students alike. Located in São Paulo, Brazil, this esteemed publication occupies a significant position in the medical field, currently holding a Q3 ranking in both the miscellaneous medicine and ophthalmology categories. Although it maintains a legacy of fluctuating impact, recognized for its contribution to the academic community, ARQUIVOS BRASILEIROS DE OFTALMOLOGIA continues to attract a diverse international readership, making it a valuable resource for advancements in eye health, surgical techniques, and ocular research.

BREAST

Advancing breast health through cutting-edge research.
Publisher: CHURCHILL LIVINGSTONEISSN: 0960-9776Frequency: 6 issues/year

BREAST is a leading peer-reviewed journal dedicated to advancing knowledge and practice in the fields of cancer research, oncology, and surgery, published by Churchill Livingstone. With an impressive impact factor and a prestigious Q1 ranking in multiple categories including Cancer Research, Medicine, and Surgery, the journal consistently delivers high-quality content that informs and inspires researchers, clinicians, and educators. Since its transition to Open Access in 2020, BREAST has significantly expanded its reach, providing immediate and unrestricted access to pivotal studies and findings in breast health and disease management. With a history dating back to 1992 and converging to 2024, the journal serves as an essential resource for the latest developments and innovative approaches in the clinical and biomedical aspects of breast care. Scholars and professionals alike can explore a wealth of research aimed at improving patient outcomes and fostering scientific dialogue in this vital area of healthcare.

Ophthalmology and Therapy

Advancing Eye Care Through Innovative Research
Publisher: SPRINGER INT PUBL AGISSN: 2193-8245Frequency: 2 issues/year

Ophthalmology and Therapy is a premier open-access journal published by Springer International Publishing AG, dedicated to advancing the field of ophthalmology through innovative research and clinical studies. With an ISSN of 2193-8245 and an E-ISSN of 2193-6528, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in eye care and vision science. The journal has achieved a remarkable impact factor and has been recognized as a Q1 journal in Ophthalmology, reflecting its contributions to the discipline and its high-quality publications. Operating from the United Kingdom, Ophthalmology and Therapy is an open-access platform that has been available since 2012, ensuring that critical research is accessible to a global audience. Its commitment to fostering collaboration and knowledge sharing is exemplified by its ranking of #39 out of 137 in the Scopus category for Medicine – Ophthalmology, placing it in the 71st percentile of its peers. Together, these attributes highlight the journal's importance as a key forum for the dissemination of cutting-edge research, making it an essential addition to the libraries of institutions and professionals engaged in ophthalmic care.

INDIAN JOURNAL OF OPHTHALMOLOGY

Pioneering Excellence in Ophthalmology Research
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0301-4738Frequency: 12 issues/year

The Indian Journal of Ophthalmology is a prestigious, peer-reviewed publication dedicated to advancing the field of ophthalmology. Published by Wolters Kluwer Medknow Publications, this journal plays a vital role in disseminating high-quality research and clinical insights since its inception in 1946. With an impact factor placing it in the Q2 category in Ophthalmology for 2023, it ranks #42 out of 137 in Scopus, reflecting its influence and reliability in the medical community. As an Open Access journal since 2005, it ensures that impactful research is accessible to a global audience, fostering innovation and knowledge sharing among researchers, healthcare professionals, and students alike. The journal's commitment to publishing cutting-edge studies, comprehensive reviews, and clinical guidelines makes it an essential resource for those navigating the rapidly evolving landscape of eye care and ophthalmology.

BMC Ophthalmology

Innovating Ophthalmology Through Open Access Research
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Ophthalmology is a premier open access journal dedicated to advancing the field of ophthalmology through the publication of high-quality, peer-reviewed research. Published by BMC in the United Kingdom, this journal has been a vital resource since its inception in 2001 and continuously contributes to the global dialogue in vision science. With an impact factor reflecting its growing influence, BMC Ophthalmology is ranked among the top quartiles (Q2) in both general medicine and ophthalmology, emphasizing its significance in medical research. The journal encourages submissions that explore innovative diagnostics, treatment approaches, and understandings of various ocular diseases, thereby appealing to researchers, clinicians, and students alike. As an open access platform, it ensures that cutting-edge research is not only published but also readily accessible to a worldwide audience, promoting further study and collaboration in this essential area of medicine.